Skip to main content
Clinical Trials/IRCT2017081215510N3
IRCT2017081215510N3Completed未知

Comparing the Efficacy of14 days Reverse Hybrid Regimen and 14 days concomitant Therapy for HP eradication

Technology Assistant, Mazandaran University Of Medical Sciences0 sites260 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
260

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 80 years (—)
Sex
All

Inclusion Criteria

  • Patients with endoscopic findings of gastric or duodenal ulcer or gastric and duodenal erosoin and have Helicobacter pylori infection ; patients older than 18 year and less than 80 years. Exclusion criteria : pregnancy and lactation ; previously received Helicobacter pylori therapy ; patients received PPI (poroton poup inhibitor) or H2 RA (histamine 2 receptor antagonist) in last 2 weeks or within 4 weeks who received antibiotics ; history of surgery on the stomach ; Patients with confirmed advanced disease , severe cardiac, pulmonary , endocrine , chronic renal failure, chronic liver disease or have cancer ; The consumption of alcoholic beverages

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Technology Assistant, Mazandaran University Of Medical Sciences

Similar Trials

Comparing the Efficacy of14 days Reverse... | Clinical Trial